Developing CRISPR Biosensors
CRISPR biosensing technology provides unambiguous pathogen detection.
molecular diagnostics
Chinook and Evotec tackle precision medicine for chronic kidney disease
With a focus on comprehensive molecular disease classification, combined with prospective clinical outcomes, Chinook has the opportunity to potentially deliver targeted therapies to the right patient populations,” he added.
